PRAMODINI MEDICARE IPO
PRAMODINI MEDICARE is a NSE SME IPO with a current status of LISTED. The price band is 110 - 118. The issue opens on 12 AUG and closes on 14 AUG. The listing date is 19 AUG.
Price Band
110 - 118
Unofficial GMP
₹0
Lot Size
1,200 shares
Minimum Investment
₹2,64,000
PRAMODINI MEDICARE IPO GMP
The latest available GMP is ₹0. Grey Market Premium is unofficial, may change frequently and does not guarantee the listing price, listing gains or investment returns.
Estimated Listing Price
₹118.00
Estimated Gain
0.0%
PRAMODINI MEDICARE IPO GMP History
0
08 AUG
0
09 AUG
0
11 AUG
0
12 AUG
0
17 AUG
PRAMODINI MEDICARE IPO Details
- IPO Type
- NSE SME
- Status
- LISTED
- Price Band
- 110 - 118
- Issue Size
- 69.04 Cr
- Issue Type
- Book Build Issue
- Fresh Issue
- ₹59.17 Cr
- Offer for Sale
- ₹5.90 Cr
- Face Value
- 10
- Lot Size
- 1,200
- Minimum Investment
- 2,64,000
- Exchange
- NSE SME
- Registrar
- Purva Sharegistry (India) Pvt.Ltd.
- Lead Managers
- Smart Horizon Capital Advisors...
- Market Maker
- ₹3.96 Cr
PRAMODINI MEDICARE IPO Dates
- Open Date
- 12 AUG
- Close Date
- 14 AUG
- Allotment Date
- 17 AUG
- Refund Date
- 14 AUG
- Demat Credit Date
- 14 AUG
- Listing Date
- 19 AUG
PRAMODINI MEDICARE IPO Subscription
- QIB
- 1.18X
- NII / HNI
- 0.17X
- Retail
- 0.39X
- Total
- 0.69X
PRAMODINI MEDICARE IPO Financials
Revenue
FY2026
₹38.24 Cr
+8.54% vs FY2025
PAT
FY2026
₹11.54 Cr
+51.44% vs FY2025
Total Assets
FY2026
₹53.27 Cr
+14.34% vs FY2025
| Particulars | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | 30.58 | 35.23 | 38.24 |
| Net Profit | 5.87 | 7.62 | 11.54 |
| Total Assets | 47.47 | 46.59 | 53.27 |
PRAMODINI MEDICARE IPO Market Lot
| Category | Lots | Shares | Investment |
|---|---|---|---|
| Retail Minimum | 2 | 2,400 | 2,64,000 |
| Retail Maximum | 2 | 2,400 | 2,64,000 |
| Small HNI | 3 | 3,600 | ₹4,24,800 |
| Big HNI | 8 | 9,600 | ₹11,32,800 |
PRAMODINI MEDICARE IPO Reservation
- QIB
- 43.27%
- NII / HNI
- 17.41%
- Retail
- 34.58%
PRAMODINI MEDICARE Promoter Holding and Anchor Allocation
- Anchor Allocation
- 23.26%
- Anchor Details
- https://www.chittorgarh.net/reports/anchor-investor/pramodini-medicare-anchor-list.pdf
PRAMODINI MEDICARE Company Overview
Company Overview :- Pramodini Medicare Limited is a healthcare diagnostics company headquartered in Vijayawada, Andhra Pradesh. The company operates in the diagnostic healthcare segment and provides medical diagnostic services through its diagnostic centres. Its activities are centered around diagnostic imaging and related healthcare testing, making the company part of India's expanding organised diagnostics industry. The business has built a presence in its operating geography and is now seeking capital through an NSE EMERGE IPO to expand its diagnostic capabilities. The proposed IPO is particularly focused on funding medical equipment for both existing and proposed diagnostic centres. This indicates that a substantial portion of the company's future growth strategy is linked to increasing diagnostic capacity and expanding its network. Financially, Pramodini Medicare has shown significant improvement. Revenue increased from ₹30.58 crore in FY23 to ₹35.22 crore in FY24 and ₹38.23 crore in FY25. More importantly, PAT increased from ₹4.28 crore in FY23 to ₹10.04 crore by FY25. For the nine months ended December 2025, the company had already reported ₹44.45 crore revenue and ₹12.56 crore PAT. FUNDAMENTALLY PROMISING — VALUATION PENDING Financial Performance: ⭐⭐⭐⭐ Profit Growth: ⭐⭐⭐⭐⭐ Debt Position: ⭐⭐⭐⭐ Business: ⭐⭐⭐⭐ Financial Analysis :- Revenue: 🟢 Growing PAT: 🟢 Strong Growth PAT Margin: 🟢 Strong Debt: 🟢 Comfortable Net Worth: 🟢 Improving Total Assets: 🟢 Expanded significantly #. Promoters :- The DRHP identifies the promoters as: 1. Dr. Chalasani Kuldeep Kumar 2. Dr. Chalasani Kavitha 3. Ms. Chalasani Durga Aashritha 4. Sri Ram Medicare Private Limited
PRAMODINI MEDICARE Business Model
Business Model :- Pramodini Medicare's business model is based on providing healthcare diagnostic services to patients through diagnostic centres. Unlike a manufacturing company, its primary assets include medical diagnostic equipment, diagnostic infrastructure, skilled healthcare professionals and its centre network. The model generates revenue whenever patients undergo diagnostic tests, scans or other medical procedures offered by its facilities. Capacity utilisation is therefore important: once expensive diagnostic equipment is installed, higher patient volumes can potentially improve operating leverage and margins. The company's IPO strategy reinforces this model. A major portion of fresh issue proceeds is proposed to fund capital expenditure for purchasing medical equipment for existing and proposed diagnostic centres. Approximately ₹45.14 crore is identified for this purpose in prospectus-based IPO information. The model has attractive characteristics when patient volumes and equipment utilisation remain strong. However, diagnostic businesses require substantial capital expenditure and depend on trained professionals, equipment availability, regulatory compliance and local brand reputation.
PRAMODINI MEDICARE Objects of the Issue
Objects of the Issue :- The major proposed objectives are: ₹45.14 crore — Funding capital expenditure for purchasing medical equipment for existing and proposed diagnostic centres. The remaining proceeds are intended for general corporate purposes and unidentified inorganic acquisition, subject to the final offer structure.
PRAMODINI MEDICARE Strengths
Strengths :- Strong profitability growth: PAT rose from ₹4.28 crore in FY23 to ₹10.04 crore in FY25. High PAT margin: Annualised FY26-based PAT margin is around 28.26%, which indicates strong reported profitability. Improving balance sheet: Debt declined substantially from ₹21.38 crore in FY23 to ₹10.80 crore in FY25. Expansion plan: IPO proceeds are intended to fund medical equipment for existing and proposed diagnostic centres. Healthcare demand: Diagnostic services can benefit from increasing healthcare awareness and preventive testing.
PRAMODINI MEDICARE Risks
Risks :- The company operates at a relatively small scale compared with India's major listed diagnostic chains. Its operations can require significant capital investment in sophisticated medical equipment. Geographical concentration can expose the company to local competitive and economic conditions. Diagnostic equipment can become technologically obsolete and require further capital expenditure. The company competes with organised diagnostic chains, hospitals and regional diagnostic centres. SME-listed shares can also experience lower liquidity and higher volatility.
PRAMODINI MEDICARE Frequently Asked Questions
What is the PRAMODINI MEDICARE IPO price band?
The PRAMODINI MEDICARE IPO price band is 110 - 118.
What is the latest PRAMODINI MEDICARE IPO GMP?
The latest available PRAMODINI MEDICARE IPO GMP in the IPOWEB database is ₹0. GMP is unofficial and does not guarantee a listing gain.
When does the PRAMODINI MEDICARE IPO open and close?
The PRAMODINI MEDICARE IPO opens on 12 AUG and closes on 14 AUG.
When is the PRAMODINI MEDICARE IPO allotment date?
The PRAMODINI MEDICARE IPO allotment date is 17 AUG.
When is the PRAMODINI MEDICARE IPO listing date?
The PRAMODINI MEDICARE IPO listing date is 19 AUG.
What is the PRAMODINI MEDICARE IPO subscription?
The latest total subscription available for the PRAMODINI MEDICARE IPO is 0.69X.